PIVOTAL‘S collaboration in children´s vaccination initiative in the poorest countries

by Pivotal

11 days ago
Child Vaccination, Gavi, Pivotal

Pivotal is collaborating with the Alliance for Child Vaccination and Gavi in the fight against children’s mortality in the world’s poorest countries.

Highlight Therapeutics y Pivotal trabajan conjuntamente en el tratamiento del melanoma y lanzan un ensayo clínico fase IIa para determinar la seguridad y eficacia de BO-112

by Pivotal

3 years ago
Highlight Therapeutics, inhibidores de checkpoint, Pivotal, melanoma metastásico

Highlight Therapeutics,(“Highlight”), una compañía biofarmacéutica clínica que desarrolla tratamientos antitumorales basados en RNA, y Pivotal, una CRO de implantación Europea y que ofrece se...

Pivotal to collaborate with Checkpoint Therapeutics on a study in patients with cutaneous squamous cell carcinoma

by Pivotal

4 years ago
Pivotal, CheckPoint Therapeutics, cSCC, skin cancer

Pivotal announced today that it has been contracted by Checkpoint Therapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...

Highlight Therapeutics & Pivotal advance into a Phase IIa trial to examine Gastro-Intestinal cancer therapy

by Pivotal

4 years ago
liver, Pivotal, Highlight Therapeutics, Gastro-Intestinal cancer

Highlight Therapeutics, (“Highlight”), a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, and Pivotal, a Europe-wide full-service CRO, today announced tha...

Staidson and Pivotal are collaborating in the conduct of a clinical trial in Europe in severe COVID-19 patients

by Pivotal

4 years ago
Staidson, Pivotal, ensayo clínico, covid-19

Staidson, a biopharmaceutical company developing investigational products by targeting the complement system and Pivotal, a European-wide full-service CRO, headquartered in Madrid, have announced t...

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

by Pivotal

5 years ago
Pivotal, clinical trials, drug, melanoma, lung cancer

Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patient enrolment has now started. Pivotal will use its deep knowledge of Oncology...

Pivotal´s milestone in the European Society for Medical Oncology Congress

by Pivotal

6 years ago
Pivotal

On Tuesday, October 23rd, the European Society for Medical Oncology Congress (ESMO) ended its annual Congress in Munich with over 26,000 oncology professionals from all over the world. This congress w...